Chris Sheldon
Head of Investor Relations, AstraZeneca
Replay available
AstraZeneca PLC (AZN) Q3 2022 Earnings Call
AstraZeneca PLC (NASDAQ: AZN) Q3 2022 earnings conference call, held 2026-11-21. Replay captured from the company's public earnings webcast.
Featured presenters
Pascal Soriot
Chief Executive Officer, AstraZeneca
Aradhana Sarin
Chief Financial Officer, AstraZeneca
Dave Fredrickson
Executive Vice President, Oncology Business Unit, AstraZeneca
Susan Galbraith
Executive Vice President, Oncology R&D, AstraZeneca
Ruud Dobber
Executive Vice President, BioPharmaceuticals, AstraZeneca
Mene Pavadassamy
Executive Vice President, IMED Biopharmaceuticals R&D, AstraZeneca
Marc Dunoyer
Chief Executive Officer, Alexion (AstraZeneca Rare Disease Business)
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for this public event.
Replay transcript excerpt
WEBVTT 00:00:00.071 -- 00:00:04.854 Good day. Welcome, ladies and gentlemen, to AstraZeneca's year-to-date and Q3 results 00:00:04.854 -- 00:00:10.396 2021 conference call and webcast for investors and analysts. 00:00:10.417 -- 00:00:14.940 Before I hand over to AstraZeneca, I'd like to read the safe harbor statement. 00:00:14.940 -- 00:00:18.882 The company intends to utilize the safe harbor revisions of the United States Private 00:00:18.882 -- 00:00:23.104 Securities Litigation Reform Act of 1995. 00:00:23.104 -- 00:00:27.327 Participants on this call may make forward-looking statements with respect to the operations 00:00:27.327 -- 00:00:30.837 and financial performance of AstraZeneca. 00:00:30.837 -- 00:00:34.760 Although we believe our expectations are based on reasonable assumptions, by their very 00:00:34.760 -- 00:00:39.564 nature, forward-looking statements involve risks and uncertainties and may be influenced 00:00:39.564 -- 00:00:44.188 by factors that could cause actual results to differ materially from those expressed 00:00:44.188 -- 00:00:47.751 or implied by these forward-looking statements. 00:00:47.751 -- 00:00:51.754 Any forward-looking statements made on this call reflect the knowledge and information 00:00:51.754 -- 00:00:54.977 available at the time of this call. 00:00:54.977 -- 00:01:00.146 The company undertakes no obligation to update forward-looking statements. 00:01:00.146 -- 00:01:04.247 Please also carefully review the forward-looking statements disclaimer in the slide deck 00:01:04.247 -- 00:01:08.148 that accompanies this conference call and webcast. 00:01:08.148 -- 00:01:11.869 There will be an opportunity to ask questions after today's presentations. 00:01:11.869 -- 00:01:16.130 If joining on the telephone, please press star 1 to indi...